<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/'><id>tag:blogger.com,1999:blog-28450497.post3886006811792421274..comments</id><updated>2008-03-14T10:25:35.210-04:00</updated><category term='Channel Management'/><category term='Supply Chain Technology'/><category term='Blog Administration'/><category term='Importation'/><category term='Health Care Policy'/><category term='Group Purchasing Organizations (GPOs)'/><category term='Drug Shortages'/><category term='Industry Trends'/><category term='Fun Stuff'/><category term='PBMs'/><category term='Wholesalers'/><category term='Pharmacy Economics'/><category term='Pharmacy'/><category term='Supply Chain Humor'/><category term='Drug Counterfeiting'/><category term='Health Care Reform'/><category term='Pharmacogenomics'/><category term='Pedigree'/><category term='Specialty Drugs'/><category term='Medicare Part D'/><category term='Average Sales Price (ASP)'/><category term='Accountable Care Organizations (ACOs)'/><category term='Generic Drugs'/><category term='Guest Post'/><category term='Marketing'/><category term='RFID'/><category term='Average Acquisition Cost (AAC)'/><category term='International Drug Channels'/><category term='Enforcement'/><category term='Costs/Reimbursement'/><category term='Average Manufacturer Price (AMP)'/><category term='Mergers and Acquisitions'/><title type='text'>Comments on Drug Channels: Diversion Risk for ABC?</title><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://www.drugchannels.net/feeds/3886006811792421274/comments/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/3886006811792421274/comments/default'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2008/03/diversion-risk-for-abc.html'/><author><name>Adam J. Fein, Ph.D.</name><uri>http://www.blogger.com/profile/12217252282643255442</uri><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='25' height='32' src='http://4.bp.blogspot.com/_jauTfEtde80/TTnq9WCPzYI/AAAAAAAAAAM/VNKwcn8y_BA/s220/AdamJFein-DrugChannels.jpg'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>4</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-28450497.post-5847291944477775878</id><published>2008-03-14T10:00:00.000-04:00</published><updated>2008-03-14T10:00:00.000-04:00</updated><title type='text'>The Anonymous post above must clearly be a Good Ne...</title><content type='html'>The Anonymous post above must clearly be a Good Neighbor Pharmacy.  Too bad for him!!  If Americsource Bergen has done such a good job combating diversion, why did they have a distribution center close?  Certainly this new situation does not help them, but hey, they "Truly know their customers"&lt;BR/&gt;&lt;BR/&gt;What about McKesson or a number of regional wholesalers who have avoided any distribution center closings??&lt;BR/&gt;&lt;BR/&gt;The fact of the matter is, whether you agree or not, is that wholesalers are forced to become the policing force.  It should be interesting to see how it all plays out.</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/3886006811792421274/comments/default/5847291944477775878'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/3886006811792421274/comments/default/5847291944477775878'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2008/03/diversion-risk-for-abc.html?showComment=1205503200000#c5847291944477775878' title=''/><author><name>Anonymous</name><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img1.blogblog.com/img/blank.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2008/03/diversion-risk-for-abc.html' ref='tag:blogger.com,1999:blog-28450497.post-3886006811792421274' source='http://www.blogger.com/feeds/28450497/posts/default/3886006811792421274' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-250748486'/></entry><entry><id>tag:blogger.com,1999:blog-28450497.post-1743728385359959406</id><published>2008-03-11T14:14:00.000-04:00</published><updated>2008-03-11T14:14:00.000-04:00</updated><title type='text'>To Anonymous (March 11):&lt;br&gt;&lt;br&gt;Um, yeah, I've bee...</title><content type='html'>To Anonymous (March 11):&lt;BR/&gt;&lt;BR/&gt;Um, yeah, I've been paying close attention.  I discussed ABC's agreement with the DEA in &lt;A HREF="http://www.drugchannels.net/2007/06/pharmacy-supply-chain-news-update.html" REL="nofollow"&gt;this post from last June.&lt;/A&gt;  Apparently, the San Diego pharmacy slipped through ABC's new system.  &lt;BR/&gt;&lt;BR/&gt;Just to be clear, I was quite careful not to "soil" ABC.  I just pointed out a little-noticed aspect of a news story.  But as I highlight in previous posts, the real challenge comes from the uncertainty associated with DEA policies regarding wholesalers.  &lt;BR/&gt;&lt;BR/&gt;Adam</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/3886006811792421274/comments/default/1743728385359959406'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/3886006811792421274/comments/default/1743728385359959406'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2008/03/diversion-risk-for-abc.html?showComment=1205259240000#c1743728385359959406' title=''/><author><name>Adam J. Fein</name><uri>http://www.blogger.com/profile/15774296048321605590</uri><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='26' height='32' src='http://www.pembrokeconsulting.com/images/fein-headshot-11.jpg'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2008/03/diversion-risk-for-abc.html' ref='tag:blogger.com,1999:blog-28450497.post-3886006811792421274' source='http://www.blogger.com/feeds/28450497/posts/default/3886006811792421274' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-1955505852'/></entry><entry><id>tag:blogger.com,1999:blog-28450497.post-7340464591691395962</id><published>2008-03-11T11:25:00.000-04:00</published><updated>2008-03-11T11:25:00.000-04:00</updated><title type='text'>If the author was paying attention, ABC took their...</title><content type='html'>If the author was paying attention, ABC took their lead from the DEA last summer.  ABC had only one DC close in Florida, but they have led the way with the DEA by putting deterents in place and truly knowing their customers.  Good Neighbor Pharmacy is an outstanding cooperative and a trademark of independent pharmacies nationwide. The name should not be soiled because of one store. &lt;BR/&gt;Unlike Cardinal, Amerisourcebergen followed the guidelines set down by the DEA. They would not have THREE distributions centers closed and add the inconvenience to their customers and themselves.</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/3886006811792421274/comments/default/7340464591691395962'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/3886006811792421274/comments/default/7340464591691395962'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2008/03/diversion-risk-for-abc.html?showComment=1205249100000#c7340464591691395962' title=''/><author><name>Anonymous</name><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img1.blogblog.com/img/blank.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2008/03/diversion-risk-for-abc.html' ref='tag:blogger.com,1999:blog-28450497.post-3886006811792421274' source='http://www.blogger.com/feeds/28450497/posts/default/3886006811792421274' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-72044678'/></entry><entry><id>tag:blogger.com,1999:blog-28450497.post-2741236784857739114</id><published>2008-03-10T13:18:00.000-04:00</published><updated>2008-03-10T13:18:00.000-04:00</updated><title type='text'>Just doodling, and thinking that since the DEA now...</title><content type='html'>Just doodling, and thinking that since the DEA now considers distributors and wholesalers to be responsible for ensuring that a pharmacy is only dispensing prescriptions issued for a legitimate medical purpose by an individual practitioner acting in the usual course of professional practice - why does DEA need so many investigators and agents assigned to this task? I think it's time that the Office of Diversion Control is restructured. They are outsourcing their primary investigative function - therefore they should have a reduction in force. I suggest that State Pharmacy Associations lobby for this reduction in force, and "encourage" the Office of Diversion Control to get back to it's core industry function. That is to say that the activities of the Office of Diversion Control include control of imports and exports of drugs and chemicals; registration of all businesses which manufacture or distribute controlled drugs, all health professionals entitled to dispense, administer or prescribe them, and all pharmacies entitled to fill prescriptions; establishment of national drug production quotas; and U.S. obligations under drug control treaties. They are responsible for understanding and implementing the CSA and the DEA regulations, as well as for writing, adopting, revising, interpreting, and applying many of these regulations. They have been woefully short in conducting their regular "business" and this should be a wake up call for all of us to point the arrows back at them. Their excuse has always been - we're too busy conducting our field investigations. Oh really? Well now you can close all unnecessary small offices, consolidate your core investigators to their inspectional duties, send the agents back to conducting investigations on the illicit side and evaluate the industry as it controls its own retail customers - pharmacies, hospitals and doctors. &lt;BR/&gt;&lt;BR/&gt;This is a good approach - REDUCE THE FORCE - you are becoming irrelevant.</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/3886006811792421274/comments/default/2741236784857739114'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/3886006811792421274/comments/default/2741236784857739114'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2008/03/diversion-risk-for-abc.html?showComment=1205169480000#c2741236784857739114' title=''/><author><name>Anonymous</name><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img1.blogblog.com/img/blank.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2008/03/diversion-risk-for-abc.html' ref='tag:blogger.com,1999:blog-28450497.post-3886006811792421274' source='http://www.blogger.com/feeds/28450497/posts/default/3886006811792421274' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-165319776'/></entry></feed>
